Detalhe da pesquisa
1.
Dynamic biomarker and imaging changes from a phase II study of pre- and post-surgical sunitinib.
BJU Int
; 130(2): 244-253, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34549873
2.
The kidney hepcidin/ferroportin axis controls iron reabsorption and determines the magnitude of kidney and systemic iron overload.
Kidney Int
; 100(3): 559-569, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991530
3.
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol.
BMC Cancer
; 21(1): 1238, 2021 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794412
4.
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK.
BMC Cancer
; 20(1): 670, 2020 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32680483
5.
Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting.
World J Urol
; 36(3): 417-425, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29256020
6.
Germline polymorphisms and survival of lung adenocarcinoma patients: a genome-wide study in two European patient series.
Int J Cancer
; 136(5): E262-71, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25196286
7.
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.
medRxiv
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38766261
8.
Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.
Acta Oncol
; 52(5): 987-93, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22943385
9.
Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans.
Elife
; 112022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35916366
10.
Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification.
Clin Cancer Res
; 28(16): 3546-3556, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35696721
11.
Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma.
Clin Cancer Res
; 27(11): 3201-3214, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741650
12.
Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.
Carcinogenesis
; 31(2): 234-8, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19955392
13.
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Genome Med
; 12(1): 23, 2020 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32111235
14.
Improving clinical trial recruitment: experience of a tertiary renal oncology centre.
Oncology
; 85(5): 297-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24217289
15.
Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS).
BMC Cancer
; 8: 244, 2008 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18715499
16.
Dose escalation of axitinib on disease progression as a strategy in the treatment of metastatic renal cell carcinoma.
ESMO Open
; 3(7): e000445, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30498581
17.
Lack of evidence that p53 Arg72Pro influences lung cancer prognosis: an analysis of survival in 619 female patients.
Lung Cancer
; 57(2): 207-12, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17400332
18.
Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis.
Nat Commun
; 8(1): 2026, 2017 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29229903
19.
Generation and Characterisation of a Pax8-CreERT2 Transgenic Line and a Slc22a6-CreERT2 Knock-In Line for Inducible and Specific Genetic Manipulation of Renal Tubular Epithelial Cells.
PLoS One
; 11(2): e0148055, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26866916
20.
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.
Cancer Res
; 76(6): 1485-1493, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26964624